
Healthcare and medicine · OncologyResearch and development · BiotechnologyResearch and development · Genetics
Aspirin reduces the risk of colorectal cancer recurrence
A new study has shown that taking a low dose of aspirin can halve the risk of colorectal cancer recurrence in patients with certain genetic mutations after surgery. This approach could significantly improve both the prognosis and accessibility of treatment for this group of patients.
0 —
